City Labs Listing Proposal:
City Labs proposed on the Egyptian Stock Market.
We Deliver Quality
About Us
Established with a mission to revolutionize healthcare services in the MENA region.
The Group has swiftly grown into a key player in diagnostics, laboratory supplies, and outpatient care.
The company is publicly listed on the Egyptian Stock Exchanges to support its ambitious growth trajectory.
Premium Healthcare Group is committed to delivering excellence through innovation, strategic acquisitions, and superior patient care.
January 10, 2024
February 29, 2024
Listing:
Officially listed on the stock exchange.
Mid-2024
Capital Increase:
The company’s capital increased to 81.4 million EGP by distributing profits as free shares, expanding to 814 million shares.
Mid-2024
Strategic Alliance with Qemet Al Mashreq :
- A 50% ownership Stock in City Labs was secured by Qemet Al Mashreq Allie, operating across Egypt, KSA, and UAE.
- Share Distribution:
- 25% of shares held by the
- 9% allocated to Qemet Al Mashreq Allie.
- The remaining 50% reserved for NileX stock market,
- Planned transfer to the Main Bourse : by the end of 2024 in the Era of Prof. Mohamed Farid (President of the Financial Regulatory Authority) and Prof. Ahmed El Sheikh (President of the Egyptian Stock Exchange Authority).
July 25, 2024
Board Restructure:
A major restructuring of City Labs’ Board of Directors was executed.
By the end of Q3 2024
Cairo Clinical Labs Full Acquisition.
September 26, 2024
Rebranding to Premium Healthcare Group (PHG):
City Labs’ token and brand identity were officially changed to “Premium Healthcare Group (PHG)”.
Growth Strategy
The Group aims to grow its laboratory network across the region by acquiring smaller labs and integrating them into its operational framework, thereby enhancing effeciency and In addition to, Partnerships with healthcare providers and insurance companies further bolster the
Labs Arm’s revenue and reach.
LEADERSHIP & GOVERNANCE
Premium Healthcare Group is led by a seasoned executive team
with decades of experience in healthcare, finance, and corporate governance. The leadership team is instrumental in driving the company’s vision and ensuring alignment with its growth objectives. The Board of Directors plays an active role in overseeing the Group’s strategic direction and compliance with international healthcare standards.
HEADQUARTERS & KEY LOCATIONS
Premium Healthcare Group is a dynamic and rapidly expanding healthcare leader
with a clear focus on providing world-class diagnostic, clinical, and supply chain services. With a robust business model, cutting-edge technology, and a commitment to ethical, patient-focused care, the Group is well-positioned to capitalize on future growth opportunities in the healthcare sector.
Vision
To become the leading healthcare provider in the MENA region
1,487,027
patients
6,739,960
tests
4000
employees
4
countries
Testimonials
What our valuable Board are saying?
- The Egyptian market shows strong potential.
- PHG holds a competitive edge in Egypt.
- PHG aims to lead the Egyptian market within three years.
- Premium Healthcare Group will secure a strong position in Saudi Arabia next year, competing for market leadership
Dr. Mahmoud Elewa
CEO
- Acquisitions are often made to obtain companies with advanced technology and talent.
- The Board is distinguished by its expertise in Medicine, Pharmaceuticals, Laboratory Sciences, Business and Engineering.
- Maintaining high-quality standards is crucial, from the internal team’s expertise to ISO certifications.
Dr. Salah Baghdadi
Chairman
- PHG is Growing Across the Region.
- PHG has 4 Arms of Diverse Medical Sectors: Labs Arm, Lab Supplies Arm, Polyclinics Arm, and Medical Centers Arm.
- PHG is a Premium Investment Opportunity.
Dr. Beshoy George
Vice Chairman
Get in touch
Are you ready for a better, more Healthcare?
Call Us Free
Call Us 24/7
+2 (057) 456 789 12
+97 (154) 525 65 82
+966 54 049 0062
Email Address
info@phg.global